ISIN: BE0974260896-XBRU Updated at

Prev close
Open
Volume
52wk Range
Capitalization

ISIN: BE0974260896-XBRU Updated at

Prev close
Open
Volume
52wk Range
Capitalization

Latest financial news

Celyad Appoints Filippo Petti as Chief Financial Officer

Celyad Appoints Filippo Petti as Chief Financial Officer

Dr. Margo Roberts joins Celyad’s Board of Directors and Scientific Committee

Dr. Margo Roberts joins Celyad’s Board of Directors and Scientific Committee

Celyad doses first AML patient at final dose level in CYAD-01 THINK trial and treats first patient with second cycle of therapy

Celyad doses first AML patient at final dose level in CYAD-01 THINK trial and treats first patient with second cycle of therapy

Celyad announces pricing of $47.3 million global offering

Celyad announces pricing of $47.3 million global offering

Discover all financial news

Investor's kit

Annual Report 2017

Annual Report 2017

Celyad interim financial report H1 2017

Celyad interim financial report H1 2017

Celyad's investors presentation

Celyad's investors presentation

Financial Calendar

August 23, 2018

Half year results 2018

November 19, 2018

Q3 2018 Business Update

Want to see more?

Know more about our regulated information